Rare condition

Strongyloidiasis

0

studies recruiting now

as of 7 Sept 2026

17

studies registered in total

as of 7 Sept 2026

0

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No recruiting trial found right now.

17 studies are registered for Strongyloidiasis, but none was recruiting as of 7 Sept 2026. Here is what is still worth doing.

Keep watching

Get an email when a new Strongyloidiasis study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Strongyloidiasis

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

1 approved treatment and 3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Ivermectin (Heartguard)
Phase 3Albendazole (Albenza)
Phase 3Moxidectin (Moxidectin component of advocate)
Phase 2Emodepside (Emodepside component of procox)

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).